Transcription factor early growth response 3 is associated with the TGF-β1 expression and the regulatory activity of CD4-positive T cells in vivo

Journal of Immunology

Volumn 191, Issue 5, 2013, Pages 2351-2359

  Sumitomo, Shuji ^a   Fujio, Keishi ^a   Okamura, Tomohisa ^a   Morita, Kaoru ^a   Ishigaki, Kazuyoshi ^a   Suzukawa, Keigo ^a   Kanaya, Kaori ^a   Kondo, Kenji ^a   Yamasoba, Tatsuya ^a   Furukawa, Asayo ^b   Kitahara, Noburou ^b   Shoda, Hirofumi ^a   Shibuya, Mihoko ^a   Okamoto, Akiko ^a   Yamamoto, Kazuhiko ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b Showa General Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EARLY GROWTH RESPONSE FACTOR 3; INTERLEUKIN 10; INTERLEUKIN 2 RECEPTOR ALPHA; MESSENGER RNA; STAT3 PROTEIN; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; GENE; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VIVO STUDY; INTERLEUKIN 10 GENE; LYMPHOCYTE ACTIVATION GENE 3; LYMPHOCYTE FUNCTION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN SECRETION; PROTEIN SYNTHESIS;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CELL SEPARATION; EARLY GROWTH RESPONSE PROTEIN 3; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; HUMANS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84883397137     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1202106     Document Type: Article

References (46)

1. Brunkow, M. E., E. W. Jeffery, K. A. Hjerrild, B. Paeper, L. B. Clark, S. A. Yasayko, J. E. Wilkinson, D. Galas, S. F. Ziegler, and F. Ramsdell. 2001. Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat. Genet. 27: 68-73.
2. Bennett, C. L., J. Christie, F. Ramsdell, M. E. Brunkow, P. J. Ferguson, L. Whitesell, T. E. Kelly, F. T. Saulsbury, P. F. Chance, and H. D. Ochs. 2001. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat. Genet. 27: 20-21.
3. Vignali, D. A., L. W. Collison, and C. J. Workman. 2008. How regulatory T cells work. Nat. Rev. Immunol. 8: 523-532.
4. Kehrl, J. H., L. M. Wakefield, A. B. Roberts, S. Jakowlew, M. Alvarez-Mon, R. Derynck, M. B. Sporn, and A. S. Fauci. 1986. Production of transforming growth factor β by human T lymphocytes and its potential role in the regulation of T cell growth. J. Exp. Med. 163: 1037-1050.
5. Kip1 act in synergy to alter the sensitivity of naive T cells to TGF-β-mediated G1 arrest through modulation of IL-2 responsiveness. J. Immunol. 173: 3093-3102.
6. Shull, M. M., I. Ormsby, A. B. Kier, S. Pawlowski, R. J. Diebold, M. Yin, R. Allen, C. Sidman, G. Proetzel, D. Calvin, et al. 1992. Targeted disruption of the mouse transforming growth factor-β 1 gene results in multifocal inflammatory disease. Nature 359: 693-699.
7. + regulatory T cells by TGF-β induction of transcription factor Foxp3. J. Exp. Med. 198: 1875-1886.
8. Davidson, T. S., R. J. DiPaolo, J. Andersson, and E. M. Shevach. 2007. Cutting Edge: IL-2 is essential for TGF-β-mediated induction of Foxp3+ T regulatory cells. J. Immunol. 178: 4022-4026.
9. Veldhoen, M., R. J. Hocking, C. J. Atkins, R. M. Locksley, and B. Stockinger. 2006. TGFβ in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 24: 179-189.
10. Bettelli, E., Y. Carrier, W. Gao, T. Korn, T. B. Strom, M. Oukka, H. L. Weiner, and V. K. Kuchroo. 2006. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441: 235-238.
11. Gorelik, L., S. Constant, and R. A. Flavell. 2002. Mechanism of transforming growth factor β-induced inhibition of T helper type 1 differentiation. J. Exp. Med. 195: 1499-1505.
12. Chen, Y., V. K. Kuchroo, J. Inobe, D. A. Hafler, and H. L. Weiner. 1994. Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science 265: 1237-1240.
13. + T cells. Nat. Med. 12: 627-635.
14. Kinjyo, I., H. Inoue, S. Hamano, S. Fukuyama, T. Yoshimura, K. Koga, H. Takaki, K. Himeno, G. Takaesu, T. Kobayashi, and A. Yoshimura. 2006. Loss of SOCS3 in T helper cells resulted in reduced immune responses and hyperproduction of interleukin 10 and transforming growth factor-β 1. J. Exp. Med. 203: 1021-1031.
15. Ogata, H., T. Chinen, T. Yoshida, I. Kinjyo, G. Takaesu, H. Shiraishi, M. Iida, T. Kobayashi, and A. Yoshimura. 2006. Loss of SOCS3 in the liver promotes fibrosis by enhancing STAT3-mediated TGF-β1 production. Oncogene 25: 2520-2530.
16. -T cells, a new subset of regulatory T cells, suppress T cell proliferation through membrane-bound TGF-β 1. J. Immunol. 182: 111-120.
17. Safford, M., S. Collins, M. A. Lutz, A. Allen, C. T. Huang, J. Kowalski, A. Blackford, M. R. Horton, C. Drake, R. H. Schwartz, and J. D. Powell. 2005. Egr-2 and Egr-3 are negative regulators of T cell activation. Nat. Immunol. 6: 472-480.
18. + T cells. J. Immunol. 173: 7331-7338.
19. Collins, S., M. A. Lutz, P. E. Zarek, R. A. Anders, G. J. Kersh, and J. D. Powell. 2008. Opposing regulation of T cell function by Egr-1/NAB2 and Egr-2/Egr-3. Eur. J. Immunol. 38: 528-536.
20. + regulatory T cells controlled by the transcription factor Egr-2. Proc. Natl. Acad. Sci. USA 106: 13974-13979.
21. Zhu, B., A. L. Symonds, J. E. Martin, D. Kioussis, D. C. Wraith, S. Li, and P. Wang. 2008. Early growth response gene 2 (Egr-2) controls the self-tolerance of T cells and prevents the development of lupuslike autoimmune disease. J. Exp. Med. 205: 2295-2307.
22. Li, S., T. Miao, M. Sebastian, P. Bhullar, E. Ghaffari, M. Liu, A. L. Symonds, and P. Wang. 2012. The transcription factors Egr2 and Egr3 are essential for the control of inflammation and antigen-induced proliferation of B and T cells. Immunity 37: 685-696.
23. Osman, G. E., M. Toda, O. Kanagawa, and L. E. Hood. 1993. Characterization of the T cell receptor repertoire causing collagen arthritis in mice. J. Exp. Med. 177: 387-395.
24. Fujio, K., Y. Misaki, K. Setoguchi, S. Morita, K. Kawahata, I. Kato, T. Nosaka, K. Yamamoto, and T. Kitamura. 2000. Functional reconstitution of class II MHC-restricted T cell immunity mediated by retroviral transfer of the αβ TCR complex. J. Immunol. 165: 528-532.
25. Morita, S., T. Kojima, and T. Kitamura. 2000. Plat-E: an efficient and stable system for transient packaging of retroviruses. Gene Ther. 7: 1063-1066.
26. Fujio, K., A. Okamoto, H. Tahara, M. Abe, Y. Jiang, T. Kitamura, S. Hirose, and K. Yamamoto. 2004. Nucleosome-specific regulatory T cells engineered by triple gene transfer suppress a systemic autoimmune disease. J. Immunol. 173: 2118-2125.
27. Stuart, J. M., A. S. Townes, and A. H. Kang. 1982. Nature and specificity of the immune response to collagen in type II collagen-induced arthritis in mice. J. Clin. Invest. 69: 673-683.
28. Trentham, D. E., A. S. Townes, and A. H. Kang. 1977. Autoimmunity to type II collagen an experimental model of arthritis. J. Exp. Med. 146: 857-868.
29. Nanki, T., Y. Urasaki, T. Imai, M. Nishimura, K. Muramoto, T. Kubota, and N. Miyasaka. 2004. Inhibition of fractalkine ameliorates murine collageninduced arthritis. J. Immunol. 173: 7010-7016.
30. Taniguchi, K., H. Kohsaka, N. Inoue, Y. Terada, H. Ito, K. Hirokawa, and N. Miyasaka. 1999. Induction of the p16INK4a senescence gene as a new therapeutic strategy for the treatment of rheumatoid arthritis. Nat. Med. 5: 760-767.
31. Ito, R., I. Katano, K. Kawai, H. Hirata, T. Ogura, T. Kamisako, T. Eto, and M. Ito. 2009. Highly sensitive model for xenogenic GVHD using severe immunodeficient NOG mice. Transplantation 87: 1654-1658.
32. Workman, D. L., and J. Clancy, Jr. 1995. Phenotypic analysis of pulmonary perivascular mononuclear infiltrates that occur as a direct result of acute lethal graft-versus-host disease describes the onset of interstitial pneumonitis. Am. J. Pathol. 147: 1350-1360.
33. Yoshimura, A., M. Suzuki, R. Sakaguchi, T. Hanada, and H. Yasukawa. 2012. SOCS, Inflammation, and Autoimmunity. Front. Immunol. 3: 20.
34. Fujio, K., A. Okamoto, Y. Araki, H. Shoda, H. Tahara, N. H. Tsuno, K. Takahashi, T. Kitamura, and K. Yamamoto. 2006. Gene therapy of arthritis with TCR isolated from the inflamed paw. J. Immunol. 177: 8140-8147.
35. + T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 389: 737-742.
36. - T cells. J. Clin. Invest. 112: 1437-1443.
37. + T cells expressing the FoxP3 transcription factor. Immunity 30: 899-911.
38. Astier, A. L., G. Meiffren, S. Freeman, and D. A. Hafler. 2006. Alterations in CD46-mediated Tr1 regulatory T cells in patients with multiple sclerosis. J. Clin. Invest. 116: 3252-3257.
39. Sakaguchi, S., T. Yamaguchi, T. Nomura, and M. Ono. 2008. Regulatory T cells and immune tolerance. Cell 133: 775-787.
40. + regulatory T cells is mediated by cell surfacebound transforming growth factor beta. J. Exp. Med. 194: 629-644.
41. + T cells expressing membrane-bound TGF-β and FOXP3. J. Clin. Invest. 114: 28-38.
42. -T cells. Retrovirology 4: 57.
43. + regulatory lymphocyte generation: implications in graft-versus-host disease and antitumor immunity. J. Immunol. 179: 7593-7604.
44. Wilamasundera, S., D. R. Katz, and B. M. Chain. 1998. Responses to human rhinovirus in CD45 T cell subsets isolated from tonsil. Eur. J. Immunol. 28: 4374-4381.
45. + T cells persist in vivo following induction of peripheral tolerance. J. Immunol. 160: 4719-4729.
46. + T cells. J. Exp. Med. 188: 1849-1857.